Kite Submits sBLA to FDA for Yescarta in Relapsed or Refractory Indolent Non-Hodgkin Lymphomas Read more
AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy Read more
Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate Read more
Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia Read more
Enesi Pharma to Develop Thermostable Solid Dose DNA Vaccine Targeting Zika Virus under New Partnership with The University of Adelaide Read more
FDA approves additional doses of Trulicity (dulaglutide) for the treatment of type 2 diabetes Read more
Registration is now open for the Pre-filled Syringes and Injectable devices Conference 2021 Read more